Platelet hyperreactivity and thrombosis are critical for dyslipidemia-induced atherosclerosis dependent on toll-like receptor 2- (TLR2-) mediated inflammatory signaling [6]. This evidence concerns the gene TLR2 and metabolic syndrome.